🔎 Trials Near Me

Akèy › Lukemi miyomonositè kwonik › Minnesota › Rochester

Etid klinik pou Lukemi miyomonositè kwonik nan Rochester, MN

6 etid pou Lukemi miyomonositè kwonik ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Ap rekriteFaz 2
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT03418038

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Ap rekriteFaz 2
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07033598

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Ap rekriteEtid obsèvasyon
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07143669

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Ap rekriteFaz 1
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT05549661

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Ap rekriteFaz 1
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT06950034

Q702 for the Treatment of Patients With Hematologic Malignancies

Ap rekriteFaz 1
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Oct 10, 2025 · NCT06712810

Etid Lukemi miyomonositè kwonik nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.